Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (avaa uuden ikkunan)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Lähde‎: Crit Care Med 2009;37(4):1299-307.

Arkistoitu‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (avaa uuden ikkunan)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (avaa uuden ikkunan)

Ball AM, Winstead PS.

Lähde‎: Pharmacotherapy 2008;28(11):1383-90.

Arkistoitu‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (avaa uuden ikkunan)

Reducing postburn injury anemia in a Jehovah's Witness patient. (avaa uuden ikkunan)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Lähde‎: J Burn Care Res 2014;35(4):e258-61.

Arkistoitu‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (avaa uuden ikkunan)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (avaa uuden ikkunan)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Lähde‎: Clin Ther 2008;30(12):2324-34.

Arkistoitu‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (avaa uuden ikkunan)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (avaa uuden ikkunan)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Lähde‎: Transplant Proc 2015;47(8):2548-51.

Arkistoitu‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (avaa uuden ikkunan)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (avaa uuden ikkunan)

Charles A, Purtill M, Napolitano LM.

Lähde‎: Anaesth Intensive Care 2006;34(6):793-6.

Arkistoitu‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (avaa uuden ikkunan)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (avaa uuden ikkunan)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Lähde‎: Crit Care Med 1999;27(11):2346-50.

Arkistoitu‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (avaa uuden ikkunan)

Erythropoietin for critically ill trauma patients: a missed opportunity? (avaa uuden ikkunan)

Corwin HL, Napolitano LM

Lähde‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Arkistoitu‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (avaa uuden ikkunan)

Postoperative management of severe acute anemia in a Jehovah's Witness. (avaa uuden ikkunan)

de Araújo Azi LM, Lopes FM, Garcia LV

Lähde‎: Transfusion 2014;54(4):1153-7.

Arkistoitu‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (avaa uuden ikkunan)

Restrictive transfusion in geriatric trauma patients. (avaa uuden ikkunan)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Lähde‎: Am Surg 2016;82(1):85-8.

Arkistoitu‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (avaa uuden ikkunan)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (avaa uuden ikkunan)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Lähde‎: J Trauma 1998;44(2):361-7.

Arkistoitu‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (avaa uuden ikkunan)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (avaa uuden ikkunan)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Lähde‎: Crit Care 2005;9(5):R508-15.

Arkistoitu‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (avaa uuden ikkunan)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (avaa uuden ikkunan)

Hong T, Shander A, Agarwal S, Castresana M.

Lähde‎: A A Case Rep 2015;4(10):127-31.

Arkistoitu‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (avaa uuden ikkunan)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (avaa uuden ikkunan)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Lähde‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Arkistoitu‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (avaa uuden ikkunan)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (avaa uuden ikkunan)

Lindholm J, Palmér K, Frenckner B.

Lähde‎: Perfusion 2012;27(4):332-4.

Arkistoitu‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (avaa uuden ikkunan)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (avaa uuden ikkunan)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Lähde‎: Am Surg 2010;76(9):951-6.

Arkistoitu‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (avaa uuden ikkunan)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (avaa uuden ikkunan)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Lähde‎: Intensive Care Med 2013;39(11):1896-908.

Arkistoitu‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (avaa uuden ikkunan)

Transfusion-free treatment strategies for acute anemia in critical care. (avaa uuden ikkunan)

Morgan CA, Byul Sarah S, Forest CP.

Lähde‎: JAAPA 2016;29(8):38-44.

Arkistoitu‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (avaa uuden ikkunan)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (avaa uuden ikkunan)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Lähde‎: J Trauma 2008;65(2):285-97.

Arkistoitu‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (avaa uuden ikkunan)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (avaa uuden ikkunan)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Lähde‎: J Trauma 2009;67(1):121-4.

Arkistoitu‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (avaa uuden ikkunan)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (avaa uuden ikkunan)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Lähde‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Arkistoitu‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (avaa uuden ikkunan)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (avaa uuden ikkunan)

Posluszny JA Jr, Napolitano LM.

Lähde‎: Transfusion 2014;54(12):3026-34.

Arkistoitu‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (avaa uuden ikkunan)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (avaa uuden ikkunan)

Price S, Pepper JR, Jaggar SI.

Lähde‎: Anesth Analg 2005;101(2):325-7.

Arkistoitu‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (avaa uuden ikkunan)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (avaa uuden ikkunan)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Lähde‎: Am Surg 2015;81(6):e263-5.

Arkistoitu‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (avaa uuden ikkunan)

Erythropoietin response is blunted in critically ill patients. (avaa uuden ikkunan)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Lähde‎: Intensive Care Med 1997;23(2):159-62.

Arkistoitu‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (avaa uuden ikkunan)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (avaa uuden ikkunan)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Lähde‎: Br J Anaesth 2005;94(4):442-4.

Arkistoitu‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (avaa uuden ikkunan)

Management of anemia in patients who decline blood transfusion. (avaa uuden ikkunan)

Shander A, Goodnough LT

Lähde‎: Am J Hematol 2018;93(9):1183-91.

Arkistoitu‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (avaa uuden ikkunan)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (avaa uuden ikkunan)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Lähde‎: Arch Surg 2012;147(3):251-5.

Arkistoitu‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (avaa uuden ikkunan)

Intravenous iron following cardiac surgery does not increase the infection rate. (avaa uuden ikkunan)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Lähde‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Arkistoitu‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (avaa uuden ikkunan)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (avaa uuden ikkunan)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Lähde‎: Crit Care 2015;19:49.

Arkistoitu‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (avaa uuden ikkunan)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (avaa uuden ikkunan)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Lähde‎: Crit Care Med 2024;52(4):618-25.

Arkistoitu‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (avaa uuden ikkunan)